The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Aberrant Regulation and Function of MicroRNAs in Cancer
Open accessAbstract
Synopsis Malignant neoplasms are consistently among the top four leading causes of death in all age groups in the United States, despite a concerted effort toward developing novel therapeutic approaches[1]. Our understanding of and therapeutic strategy for treating each of these neoplastic diseases has been elevated through decades of research on the genetics, signaling pathways, and cellular biology that govern tumor cell initiation, progression and maintenance. Much of this work has concentrated on post-translational modifications and abnormalities at the DNA level, including point mutations, amplifications/deletions, and chromosomal translocations, and how these aberrant events affect the expression and function of protein-coding genes. Only recently has a novel class of conserved gene regulatory molecules been identified as major contributors to malignant neoplastic disease. This review focuses on how these small non-coding RNA molecules, termed microRNAs (miRNAs), can function as oncogenes or tumor suppressors, and how the misexpression of miRNAs and dysregulation of factors that regulate miRNAs contributes to the tumorigenic process. Specific focus is given to more recently discovered regulatory mechanisms that go awry in cancer, and how these changes alter miRNA expression, processing, and function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
6 retracted
Fukuda, T., Yamagata, K., Fujiyama, S., Matsumoto, T., Koshida, I., Yoshimura, K., Mihara, M., Naitou, M., Endoh, H., Nakamura, T., et al. (2007) · Nature Cell Biology · doi:10.1038/ncb1577 · Cited by 428
RetractedWatanabe, M., Yanagisawa, J., Kitagawa, H., Takeyama, K.-I., Ogawa, S., Arao, Y., Suzawa, M., Kobayashi, Y., Yano, T., Yoshikawa, H., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.6.1341 · Cited by 267
RetractedHMGA2 functions as a competing endogenous RNA to promote lung cancer progression
Kumar, M. S., Armenteros-Monterroso, E., East, P., Chakravorty, P., Matthews, N., Winslow, M. M., & Downward, J. (2014) · Nature · doi:10.1038/nature12785 · Cited by 253
RetractedRETRACTED: Maturation of MicroRNA Is Hormonally Regulated by a Nuclear Receptor
Yamagata, K., Fujiyama, S., Ito, S., Ueda, T., Murata, T., Naitou, M., Takeyama, K.-I., Minami, Y., O'Malley, B. W., & Kato, S. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.08.017 · Cited by 197
RetractedMaturation of MicroRNA Is Hormonally Regulated by a Nuclear Receptor
Yamagata, K., Fujiyama, S., Ito, S., Ueda, T., Murata, T., Naitou, M., Takeyama, K., Minami, Y., O’Malley, B. W., & Kato, S. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.02.011 · Cited by 71
RetractedRNA editing in human cancer: review
Škarda, J., Amariglio, N., & Rechavi, G. (2009) · Apmis · doi:10.1111/j.1600-0463.2009.02505.x · Cited by 10
RetractedMicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310 · cited 1×
“While normally only expressed at high levels during development, these small proteins are unique in their ability to convert human somatic cells to pluripotency when co-expressed with the reprogramming factors OCT4, NANOG and SOX2 [33].”
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
Salmena, L., Poliseno, L., Tay, Y., Kats, L., & Pandolfi, P. P. (2011) · Cell · doi:10.1016/j.cell.2011.07.014 · Cited by 7,262
Cited by
The Fibroblast Growth Factor signaling pathway
Ornitz, D. M., & Itoh, N. (2015) · WIREs Developmental Biology · doi:10.1002/wdev.176 · Cited by 2,050
miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database
Chou, C.-H., Chang, N.-W., Shrestha, S., Hsu, S.-D., Lin, Y.-L., Lee, W.-H., Yang, C.-D., Hong, H.-C., Wei, T.-Y., Tu, S.-J., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1258 · Cited by 1,831
The role of non-coding RNAs in oncology
Slack, F. J., & Chinnaiyan, A. M. (2019) · Cell · doi:10.1016/j.cell.2019.10.017 · Cited by 1,619
Self-citationmiRTarBase 2020: updates to the experimentally validated microRNA–target interaction database
Huang, H.-Y., Lin, Y.-C.-D., Li, J., Huang, K.-Y., Shrestha, S., Hong, H.-C., Tang, Y., Chen, Y.-G., Jin, C.-N., Yu, Y., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz896 · Cited by 1,259
Targeting noncoding RNAs in disease
Adams, B. D., Parsons, C., Walker, L., Zhang, W. C., & Slack, F. J. (2017) · Journal of Clinical Investigation · doi:10.1172/jci84424 · Cited by 673
Self-citationA network-biology perspective of microRNA function and dysfunction in cancer
Bracken, C. P., Scott, H. S., & Goodall, G. J. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.134 · Cited by 668
An integrated expression atlas of miRNAs and their promoters in human and mouse
The FANTOM Consortium, de Rie, D., Abugessaisa, I., Alam, T., Arner, E., Arner, P., Ashoor, H., Åström, G., Babina, M., Bertin, N., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3947 · Cited by 561
Fromm, B., Billipp, T., Peck, L. E., Johansen, M., Tarver, J. E., King, B. L., Newcomb, J. M., Sempere, L. F., Flatmark, K., Hovig, E., et al. (2015) · Annual Review of Genetics · doi:10.1146/annurev-genet-120213-092023 · Cited by 537
Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer
Carethers, J. M., & Jung, B. H. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.06.047 · Cited by 483
“Their main function is to bind mRNA via complementary base pairing with the 3′ untranslated region (3′-UTR), or in rare cases the 5′-UTR or coding sequences, causing degradation of that mRNA if the base pairing is fully matched, or silences the mRNA if the base pairing is only partially matched [36,37].”
BackgroundZhou, Y., Ren, H., Dai, B., Li, J., Shang, L., Huang, J., & Shi, X. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0965-2 · Cited by 456
dbDEMC 2.0: updated database of differentially expressed miRNAs in human cancers
Yang, Z., Wu, L., Wang, A., Tang, W., Zhao, Y., Zhao, H., & Teschendorff, A. E. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1079 · Cited by 340
Role of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature review
Chiurillo, M. A. (2015) · World Journal of Experimental Medicine · doi:10.5493/wjem.v5.i2.84 · Cited by 317
The Whereabouts of microRNA Actions: Cytoplasm and Beyond
Leung, A. K. L. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.07.005 · Cited by 186
The regulatory role of miRNAs on VDR in breast cancer
Singh, T., & Adams, B. D. (2017) · Transcription · doi:10.1080/21541264.2017.1317695 · Cited by 37
“miRNAs are transcribed as primary miRNAs in the nucleus of the cell, and are enzymatically processed in the nucleus by a family of RNAseIII enzymes including DROSHA and AGO2.(78,1,2) The residual 85-nt hairpin structures termed pre-miRNAs are exported into the cytoplasm.”
BackgroundSelf-citation
Metadata
- Authors
- Adams, B. D., Kasinski, A. L., & Slack, F. J.
- Venue
- Current Biology
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 24
- Issue
- 16
- Pages
- R762-R776
- ISSN
- 0960-9822 (ISSN-L)
- OpenAlex
- W1991153319
- Cited by
- 471
- References
- 145
- FWCI
- 14.97
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.